These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28760202)

  • 1. High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease.
    Sara JDS; Prasad M; Zhang M; Lennon RJ; Herrmann J; Lerman LO; Lerman A
    Am Heart J; 2017 Aug; 190():1-11. PubMed ID: 28760202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Troponin in Patients With Coronary Artery Endothelial Dysfunction.
    El Sabbagh A; Prasad M; Zack CJ; Widmer RJ; Karon BS; Lerman A; Jaffe AS
    J Invasive Cardiol; 2018 Nov; 30(11):406-410. PubMed ID: 30373950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects.
    Hasdai D; Gibbons RJ; Holmes DR; Higano ST; Lerman A
    Circulation; 1997 Nov; 96(10):3390-5. PubMed ID: 9396432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma.
    Dhawan SS; Corban MT; Nanjundappa RA; Eshtehardi P; McDaniel MC; Kwarteng CA; Samady H
    Atherosclerosis; 2012 Aug; 223(2):384-8. PubMed ID: 22766333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
    Huang W; Chen QW; Lei H; Deng W; Ke DZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.
    Prasad M; Matteson EL; Herrmann J; Gulati R; Rihal CS; Lerman LO; Lerman A
    Hypertension; 2017 Feb; 69(2):236-242. PubMed ID: 27993955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
    Nidorf M; Thompson PL
    Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
    Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
    Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: findings from the TweeSteden Mild Stenosis Study (TWIST).
    Mommersteeg PM; Meeuwis SH; Denollet J; Widdershoven JW; Aarnoudse W; Westerhuis BL; Kop WJ
    J Psychosom Res; 2014 Nov; 77(5):426-9. PubMed ID: 25307791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
    Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
    Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography.
    Seo WW; Kim HL; Kim YJ; Yoon YE; Lee SP; Kim HK; Cho GY; Zo JH; Choi DJ; Sohn DW
    J Cardiol; 2016 Sep; 68(3):222-8. PubMed ID: 26481470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
    Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
    Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.